CASP3 and B-cell chronic lymphocytic leukemia: As shown in Fig. 3, treatment of CLL cells with Antho 50 induced a decrease in UHRF1 expression accompanied by progressive activation of caspase 3 providing further evidence for the pro-apoptotic properties of Antho 50.